Evidence map›Paper›PMID 34903275›Full record

ReviewJournal of medical case reports2021

Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: a case report and review of the literature.

Bruno Kusznir Vitturi, Marina Grandis, Sabrina Beltramini, Andrea Orsi, Angelo Schenone, Giancarlo Icardi, Paolo Durando

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Journal of medical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. IncreasedBMC neurology · 2023
    Article
  12. Parsonage-Turner Syndrome After COVID-19 Vaccination in a Child.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2023
    Article
  13. Article
  14. Article
  15. Co-VAN study: COVID-19 vaccine associated neurological diseases- an experience from an apex neurosciences centre and review of the literature.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bruno Kusznir VitturiDepartment of Health Sciences, University of Genoa, L.go R. Benzi, 10 (Building 3), 16122, Genoa, Italy. z_azul@hotmail.com.
Marina GrandisDINOGMI, University of Genoa, Genoa, Italy.
Sabrina BeltraminiPharmacy Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Andrea OrsiHygiene Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Angelo SchenoneDINOGMI, University of Genoa, Genoa, Italy.
Giancarlo IcardiDepartment of Health Sciences, University of Genoa, L.go R. Benzi, 10 (Building 3), 16122, Genoa, Italy.
Paolo DurandoDepartment of Health Sciences, University of Genoa, L.go R. Benzi, 10 (Building 3), 16122, Genoa, Italy.
Ospedale Policlinico San Martino · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParsonage-Turner syndrome is an acute peripheral neuropathy that affects the upper brachial plexus region. Previously published reports demonstrate that the condition can be triggered by surgery, infection, autoimmune diseases, strenuous exercise, trauma, radiation, and vaccination. Parsonage-Turner syndrome has already been reported in three other patients who were vaccinated against coronavirus disease 2019. CASE PRESENTATION: We report the case of a 51-year-old Caucasian man without comorbidities who received the first dose of the ChAdOx1-S recombinant vaccine (Vaxzevria, AstraZeneca, Oxford, UK) against coronavirus disease 2019 and was diagnosed with Parsonage-Turner syndrome. A few days after getting vaccinated, the patient reported a progressive increase in pain in the region of vaccine administration. One month later, the shoulder pain was followed by symptoms of hypoesthesia and muscle weakness on abduction and elevation of the left upper limb. Neurological examination revealed an atrophy of the proximal muscles of the left upper limb, accompanied by paresis of the left deltoid, biceps brachii, triceps brachii, and infraspinatus muscles. Electroneuromyography carried out 3 months after the onset of symptoms showed signs consistent with brachial plexus neuritis. The adverse reaction has been properly reported to the Italian Pharmacovigilance System (Italian Medicines Agency-Agenzia Italiana del Farmaco.

conclusionThe increased awareness of such association is essential for early identification and diagnosis and, thus, better clinical outcomes.

Indexed as

Brachial Plexus NeuritisCOVID-19VaccinesHumansMaleMiddle AgedSARS-CoV-2VaccinationVaccinesAcute brachial neuritisAdverse reactionsCOVID-19COVID-19 vaccinesNeuralgic amyotrophyParsonage–Turner syndrome

Identifiers

PMID34903275
PMCPMC8667016
OpenAlexW4200213846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.